Haleon Plc - ADR (HLN) | Stock Overview & Key Data
Haleon Plc - ADR Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $11.42 on June 2, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2024
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Haleon Plc - ADR
HLN
|
42.40B Large-cap | 2.02% | 1.23% | -13.29% | -7.73% | -9.30% | -16.01% | 8.43% | 23.21% | 23.21% | 23.21% | 23.21% |
|
Zoetis
ZTS
|
49.75B Large-cap | 0.16% | 3.42% | -31.08% | -32.94% | -36.81% | -51.58% | -53.40% | -57.08% | 71.34% | 156.59% | 156.59% |
|
United Therapeutics
UTHR
|
25.11B Large-cap | 0.90% | -3.34% | 2.86% | 9.85% | 10.64% | 92.68% | 137.11% | 205.88% | 434.68% | 903.79% | 2,026.01% |
|
Viatris
VTRS
|
16.99B Large-cap | 2.45% | -0.97% | 20.80% | 39.97% | 30.98% | 84.75% | 60.16% | 15.57% | -63.39% | -26.00% | -21.07% |
|
Intra-Cellular
ITCI
|
14.05B Large-cap | N/A | N/A | N/A | N/A | N/A | 92.68% | 104.13% | 700.67% | 449.92% | 632.61% | 632.61% |
| 14.00B Large-cap | -20.10% | -40.20% | -24.65% | -0.98% | -16.80% | 20.24% | 2,888.89% | 6,625.00% | 6,625.00% | 6,625.00% | 6,625.00% |
Ownership & Short Interest
Calculate Your Haleon Plc - ADR Investment Returns
Long-Term Investment Performance Analysis
Haleon Plc - ADR stock price in Jul 2022 was $7.41, A $1,000.00 lump sum investment in Haleon Plc - ADR made 3 years ago would be worth approximately $1,224.02 today, representing a positive return of 22.40%. This translates to an annualized return (CAGR) of 5.31%.
3 Years 10 Months Investment Scenario (Jul 2022 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is HLN's 52-week high and low?
- In the last 52 weeks, Haleon Plc - ADR reached a high of $11.28 (on February 18, 2026) and a low of $8.65 (on June 3, 2026).
- What is the market cap and P/E ratio for HLN?
- Curious about Haleon Plc - ADR's size and valuation? Its market capitalization stands at 42.40B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.72, and the forward P/E (looking ahead) is 15.42.
- Does HLN pay dividends? If so, what's the yield?
- Yes, Haleon Plc - ADR is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.63%, and the company has paid an average of $0.11 per share annually over the past 3 years.
- Who are Haleon Plc - ADR's main competitors or similar companies to consider before investing?
When looking at Haleon Plc - ADR, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS49.75B Healthcare Drug Manufacturers - Specialty & Generic -51.58% -53.40% United Therapeutics
UTHR25.11B Healthcare Drug Manufacturers - Specialty & Generic 92.68% 137.11% Viatris
VTRS16.99B Healthcare Drug Manufacturers - Specialty & Generic 84.75% 60.16% Intra-Cellular
ITCI14.05B Healthcare Drug Manufacturers - Specialty & Generic 92.68% 104.13% Regencell Bioscience
RGC14.00B Healthcare Drug Manufacturers - Specialty & Generic 20.24% 2,888.89% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Haleon Plc - ADR? (e.g., ROE, Debt/Equity)
- To get a sense of Haleon Plc - ADR's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.27%, the Debt to Equity ratio from the most recent quarter is 52.37, and its Gross Profit Margin stands at 55.38%.
- What is the recent revenue and earnings growth for HLN?
- Looking at Haleon Plc - ADR's growth, its revenue over the trailing twelve months (TTM) was $15B. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.60%, and quarterly earnings saw a YoY growth of 86.40%.
- How much of HLN stock is held by insiders and institutions?
- Wondering who owns Haleon Plc - ADR stock? Company insiders (like executives and directors) hold about 0.01% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.74%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.